---
schema_version: "secwatch.filing_event.v1"
accession: "0001093557-26-000025"
form_type: "8-K"
ticker: "DXCM"
cik: "0001093557"
company_name: "DEXCOM INC"
filed_at: "2026-02-12T23:59:59+00:00"
generated_at: "2026-05-16T02:54:53.467275+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Dexcom Q4 revenue $1.26B (+13% YoY); GAAP EPS $0.68; FY2026 guidance $5.16-5.25B

## Summary
- GAAP operating income $323M (25.6% margin), up 860bps YoY; Non-GAAP op income $331.5M.
- U.S. revenue +11% YoY; international +18% (organic +15%); G7 15-day CGM launched in U.S.
- Full year 2025 revenue $4.662B (+16%); GAAP operating margin 19.6%, up 470bps.
- FY2026 guidance: revenue $5.16-5.25B (11-13% growth); Non-GAAP op margin ~22-23%.
- Cash & marketable securities $2.0B; revolving credit facility undrawn.

## SEC filing metadata
- accession: 0001093557-26-000025
- form_type: 8-K
- ticker: DXCM
- cik: 0001093557
- company_name: DEXCOM INC
- filed_at: 2026-02-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1093557/000109355726000025/0001093557-26-000025-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1093557/000109355726000025/dxcm-20260212.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001093557-26-000025
- JSON: https://secwatch.observer/filing/0001093557-26-000025.json
- Plain text: https://secwatch.observer/filing/0001093557-26-000025.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.